Scandinavian journal of immunology · 2023
Clinical, immunological and molecular findings of patients with DOCK-8 deficiency from India.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gowri Vijaya, Chougule Akshaya, Gupta Maya, Taur Prasad, Iyengar Vaishnavi V, Sivasankaran Meena, Munirathnam Deenadayalan, Krishna Sushma, Bargir Umair A, Dalvi Aparna, Setia Priyanka, Jodhawat Neha, Shinde Shweta, Prabhu Shakuntala S, Bodhanwala Minnie, Madkaikar Manisha R, Desai Mukesh M
Аннотация
DOCK8 deficiency affects various cell subsets belonging to both the innate and adaptive immune systems. Clinical diagnosis is challenging, as many cases present with severe atopic dermatitis as the only initial manifestation. Though flow cytometry helps in the presumptive diagnosis of DOCK8-deficient patients by evaluating their DOCK8 protein expression, it requires subsequent confirmation by molecular genetic analysis. Currently, haematopoietic stem cell transplantation (HSCT) is the only curative treatment option available for these patients. There is a paucity of data from India on the clinical diversity and molecular spectrum of DOCK8 deficiency. In the present study, we report the clinical, immunological and molecular findings of 17 DOCK8-deficient patients from India diagnosed over the last 5 years.